JP2015529198A5 - - Google Patents

Download PDF

Info

Publication number
JP2015529198A5
JP2015529198A5 JP2015528571A JP2015528571A JP2015529198A5 JP 2015529198 A5 JP2015529198 A5 JP 2015529198A5 JP 2015528571 A JP2015528571 A JP 2015528571A JP 2015528571 A JP2015528571 A JP 2015528571A JP 2015529198 A5 JP2015529198 A5 JP 2015529198A5
Authority
JP
Japan
Prior art keywords
compound
immunogenic carrier
conjugate
protein
nhc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015528571A
Other languages
English (en)
Japanese (ja)
Other versions
JP6131415B2 (ja
JP2015529198A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/055724 external-priority patent/WO2014031600A1/en
Publication of JP2015529198A publication Critical patent/JP2015529198A/ja
Publication of JP2015529198A5 publication Critical patent/JP2015529198A5/ja
Application granted granted Critical
Publication of JP6131415B2 publication Critical patent/JP6131415B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015528571A 2012-08-21 2013-08-20 イムノアッセイに使用するためのクエチアピンのハプテン Active JP6131415B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261691462P 2012-08-21 2012-08-21
US61/691,462 2012-08-21
PCT/US2013/055724 WO2014031600A1 (en) 2012-08-21 2013-08-20 Haptens of quetiapine for use in immunoassays

Publications (3)

Publication Number Publication Date
JP2015529198A JP2015529198A (ja) 2015-10-05
JP2015529198A5 true JP2015529198A5 (enExample) 2016-04-14
JP6131415B2 JP6131415B2 (ja) 2017-05-24

Family

ID=49081009

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015528571A Active JP6131415B2 (ja) 2012-08-21 2013-08-20 イムノアッセイに使用するためのクエチアピンのハプテン

Country Status (10)

Country Link
US (1) US9304126B2 (enExample)
EP (2) EP3305784B1 (enExample)
JP (1) JP6131415B2 (enExample)
CN (2) CN104736536B (enExample)
AU (2) AU2013305935B2 (enExample)
CA (1) CA2882557C (enExample)
ES (2) ES2822907T3 (enExample)
PL (2) PL2888257T3 (enExample)
PT (2) PT3305784T (enExample)
WO (1) WO2014031600A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015529199A (ja) 2012-08-21 2015-10-05 オルソ−クリニカル ダイアグノスティクス,インコーポレイティド パリペリドンハプテンに対する抗体及びその使用
PT3305784T (pt) * 2012-08-21 2020-10-23 Janssen Pharmaceutica Nv Haptenos de quetiapina para utilização em ensaios imunológicos
EP2888277A4 (en) 2012-08-21 2016-05-18 Ortho Clinical Diagnostics Inc ANTIBODIES AGAINST PALIPERIDONE AND USE THEREOF
PL2888373T3 (pl) 2012-08-21 2018-08-31 Janssen Pharmaceutica Nv Przeciwciała dla arypiprazolu i ich zastosowanie
WO2014031645A1 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc Antibodies to risperidone haptens and use thereof
ES2654413T3 (es) 2012-08-21 2018-02-13 Janssen Pharmaceutica, N.V. Anticuerpos a quetiapina y uso de los mismos
WO2014031584A1 (en) 2012-08-21 2014-02-27 Janssen Pharmaceutica Nv Haptens of aripiprazole and their use in immunoassays
PL2888286T3 (pl) * 2012-08-21 2018-07-31 Janssen Pharmaceutica Nv Przeciwciała skierowane przeciwko haptenom kwetiapinowym i ich zastosowanie
ES3057437T3 (en) 2012-08-21 2026-03-02 Janssen Pharmaceutica Nv Antibodies to olanzapine haptens and use thereof
AU2013305970B2 (en) 2012-08-21 2017-08-17 Saladax Biomedical Inc. Antibodies to aripiprazole haptens and use thereof
WO2014031662A2 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc Antibodies to olanzapine and use thereof
ES2870004T3 (es) 2012-08-21 2021-10-26 Janssen Pharmaceutica Nv Anticuerpos contra la risperidona y uso de los mismos
FI3259593T3 (fi) * 2015-02-20 2023-01-13 Homogeeninen immunomääritys, jossa on taustasignaalikompensointi
CN108368180B (zh) 2015-12-17 2022-07-26 詹森药业有限公司 喹硫平的抗体及其用途
JP6949025B2 (ja) 2015-12-17 2021-10-13 ヤンセン ファーマシューティカ エヌ.ベー. リスペリドンに対する抗体及びその使用
CN111246918B (zh) 2017-10-19 2024-06-14 艾德克斯实验室公司 对称二甲基精氨酸的检测
JP2022524103A (ja) 2019-03-08 2022-04-27 メビオン・メディカル・システムズ・インコーポレーテッド カラム別の放射線の照射およびそのための治療計画の生成
CN111808046B (zh) * 2020-06-30 2022-11-11 杭州同舟生物技术有限公司 一种喹硫平人工半抗原、人工抗原及其制备方法和应用
CN116354904B (zh) * 2023-04-26 2023-08-01 北京丹大生物技术有限公司 一种喹硫平衍生物半抗原、抗原、抗喹硫平抗体及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
DE69329887T2 (de) 1992-05-29 2001-05-23 Eli Lilly And Co., Ltd. Thienobenzodiazepinderivate zur Behandlung von Störungen des Zentralnervensystems
US6034078A (en) 1992-05-29 2000-03-07 Eli Lilly And Company Limited Thienobenzodiazepine compounds
US5395933A (en) 1992-08-07 1995-03-07 Eastman Kodak Company Carbamazepine hapten analogues
US6958156B2 (en) 2000-12-15 2005-10-25 Vyrex Corporation Isoflavone derivatives
US7193065B2 (en) * 2001-07-13 2007-03-20 Roche Diagnostics Operations, Inc. Protease inhibitor conjugates and antibodies useful in immunoassay
EP1492794B1 (en) 2002-03-28 2007-12-12 Eli Lilly And Company Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
ES2285227T3 (es) 2002-08-05 2007-11-16 Eli Lilly And Company Arilbenzodiazepinas sustituidas con piperazina.
PT1664007E (pt) * 2003-09-23 2010-02-15 Fermion Oy Preparação de quetiapina
TW200616604A (en) 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
FR2878850B1 (fr) * 2004-12-02 2008-10-31 Cis Bio Internat Sa Derives de l'inositol-1-phosphate
JP2010540920A (ja) * 2007-09-27 2010-12-24 ノバルティス アーゲー 薬物モニタリングアッセイ
WO2010033270A1 (en) * 2008-09-17 2010-03-25 Auspex Pharmaceuticals, Inc. Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
TW201020258A (en) 2008-10-14 2010-06-01 Astrazeneca Ab Chemical compounds 542
EP2194048A1 (en) 2008-12-02 2010-06-09 Dirk Sartor Nitrate esters for the treatment of vascular and metabolic diseases
CN107714703A (zh) * 2009-12-31 2018-02-23 凯姆制药公司 喹硫平的氨基酸缀合物、其制备和使用方法
RS58335B1 (sr) * 2010-03-11 2019-03-29 Kempharm Inc Konjugati kvetiapina sa masnom kiselinom, proces za njihovo dobijanje i njihova primena
US8088594B2 (en) 2010-03-16 2012-01-03 Saladax Biomedical Inc. Risperidone immunoassay
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
US8623324B2 (en) 2010-07-21 2014-01-07 Aat Bioquest Inc. Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
JP5757497B2 (ja) * 2010-10-06 2015-07-29 公立大学法人大阪府立大学 シガトキシン類ctx1bおよび54−デオキシ−ctx1bを認識するモノクローナル抗体およびそれを用いるシガトキシン類検出キット
WO2013088255A1 (en) 2011-12-15 2013-06-20 Alkermes Pharma Ireland Limited Prodrugs of secondary amine compounds
PT3305784T (pt) * 2012-08-21 2020-10-23 Janssen Pharmaceutica Nv Haptenos de quetiapina para utilização em ensaios imunológicos

Similar Documents

Publication Publication Date Title
JP2015529197A5 (enExample)
EP4253075A3 (en) N,n'-diarylurea derivative, manufacturing method thereof, and thermosensitive recording material using same
JP2015527363A5 (enExample)
JP2017222671A5 (enExample)
BR112014029578A2 (pt) composto heterocíclico fundido
UY35854A (es) Métodos para la conjugación de oxima con polipéptidos ceto-modificados
AR121291A2 (es) Proceso para la recuperación de un metal de una mena
EA200801372A1 (ru) Способы получения замещенных пиримидинов
BR112015032689A2 (pt) composto heterocíclico fundido e uso em controle de pragas do mesmo
ES2571483T3 (es) Producto intermedio para producir un éster de ácido sulfónico cíclico
NO20084278L (no) Bezothiazol derivatives as beta2 adrenoreceptor agonists
RU2015138503A (ru) Способ экстракции и выделения
IL291939B (en) Methods for the preparation of 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylic acid
EA201070589A1 (ru) Способ получения морфийных соединений
WO2013132065A3 (de) Mikromechanisches messelement und verfahren zur herstellung eines mikromechanischen messelements
CY1123757T1 (el) Διεργασια για παρασκευη ενωσεων καρβοξαμιδιων ινδολης
EA201201127A1 (ru) Способ получения небиволола
BRPI0606676A2 (pt) processos para a preparação de derivados de ácido 4-(fenóxi-5-metil-pirimidin-4-ilóxi)piperidina-1-carboxì lico e compostos relacionados
BR112017012537A2 (pt) copolímero de álcool polimetalílico e corpo moldado que contém o mesmo e método de produção de copolímero de álcool polimetalílico
PH12015501636B1 (en) Method for preparing 1-(4-(4-(3,4 - dichloro -2- fluorophenylamino)-7- methoxyquinazolin -6- yloxy) piperidin -1-yl) prop-2-en-1-one
DK1763586T3 (da) Ny sekvens til forbedring af ekspressionen af nukleinsyre
EA201270390A1 (ru) 1,2,4-триазин, который может быть использован в качестве ускорителя вулканизации, и способ его получения
EA200971019A1 (ru) Способы получения (r)-2-метилпирролидина и (s)-2-метилпирролидина и их солей винной кислоты
EA200900257A1 (ru) Полиморфные формы сульфатов зипразидона
EA201071164A1 (ru) Жидкие и лиофилизованные композиции